blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0885614

EP0885614 - Method of ex vivo immunizing using heterologous intact bispecific and/or trispecific antibodies [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.07.2001
Database last updated on 29.06.2024
Most recent event   Tooltip15.06.2007Lapse of the patent in a contracting state
New state(s): LU		published on 18.07.2007  [2007/29]
Applicant(s)For all designated states
GSF-Forschungszentrum für Umwelt und Gesundheit GmbH
Ingolstädter Landstrasse 1
85764 Oberschleissheim / DE
[N/P]
Former [1998/52]For all designated states
GSF-Forschungszentrum für Umwelt und Gesundheit, GmbH
Ingolstädter Landstrasse 1
85764 Oberschleissheim / DE
Inventor(s)01 / Lindhofer, Horst, Dr.
Pilsenseeweg 4
82194 Gröbenzell / DE
02 / Kolb, Hans-Jochem, Prof. Dr.
Lerchenauerstrasse 39
80804 München / DE
03 / Zeidler, Reinhard, Dr.
Leisaustrasse 12
81249 München / DE
04 / Bornkamm, Georg, Prof. Dr.
Otilostrasse 6a
81243 München / DE
[1998/52]
Representative(s)Isarpatent
Patent- und Rechtsanwälte Barth
Charles Hassa Peckmann & Partner mbB
Postfach 44 01 51
80750 München / DE
[N/P]
Former [1998/52]Reinhard - Skuhra - Weise & Partner
Postfach 44 01 51
80750 München / DE
Application number, filing date98110972.116.06.1998
[1998/52]
Priority number, dateDE1997102558617.06.1997         Original published format: DE 19725586
[1998/52]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report 
No.:EP0885614
Date:23.12.1998
Language:DE
[1998/52]
Type: A3 Search report 
No.:EP0885614
Date:13.01.1999
[1999/02]
Type: B1 Patent specification 
No.:EP0885614
Date:27.09.2000
Language:DE
[2000/39]
Search report(s)(Supplementary) European search report - dispatched on:EP02.12.1998
ClassificationIPC:A61K39/395, A61K45/00
[2000/20]
CPC:
A61K35/13 (EP,US); A61K41/17 (EP,US); A61K35/17 (EP,US);
A61K39/0011 (EP,US); A61P35/00 (EP); A61P37/04 (EP);
C07K16/2809 (EP,US); C07K16/30 (EP,US); C07K2319/00 (EP,US) (-)
C-Set:
A61K35/13, A61K2300/00 (EP,US);
A61K35/17, A61K2300/00 (US,EP)
Former IPC [1999/01]A61K39/395, A61K45/05
Former IPC [1998/52]A61K39/395
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1999/38]
Former [1998/52]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE 
TitleGerman:Verfahren zur ex vivo-Immunisierung mittels heterologer intakter bispezifischer und/oder trispezifischer Antikörper[1998/52]
English:Method of ex vivo immunizing using heterologous intact bispecific and/or trispecific antibodies[1998/52]
French:Procédé d'immunisation ex vivo utilisant des anticorps hétérologues intactes bispécifiques ou trispécifiques[1998/52]
Examination procedure19.02.1999Examination requested  [1999/16]
19.02.1999Request for accelerated examination filed
04.05.1999Despatch of a communication from the examining division (Time limit: M04)
04.05.1999Decision about request for accelerated examination - accepted: Yes
13.07.1999Loss of particular rights, legal effect: designated state(s)
30.07.1999Reply to a communication from the examining division
21.10.1999Despatch of communication of loss of particular rights: designated state(s) CY
26.11.1999Despatch of communication of intention to grant (Approval: Yes)
31.03.2000Communication of intention to grant the patent
12.05.2000Fee for grant paid
12.05.2000Fee for publishing/printing paid
Opposition(s)28.06.2001No opposition filed within time limit [2001/37]
Fees paidRenewal fee
29.06.2000Renewal fee patent year 03
Penalty fee
Penalty fee Rule 85a EPC 1973
12.08.1999CY   M01   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipES27.09.2000
PT27.12.2000
GR29.12.2000
LU16.06.2001
[2007/29]
Former [2005/01]ES27.09.2000
PT27.12.2000
GR29.12.2000
Former [2002/27]ES27.09.2000
PT27.12.2000
Former [2001/18]PT27.12.2000
Documents cited:Search[PY]EP0826695  (GSF FORSCHUNGSZENTRUM UMWELT [DE]) [PY] 1-26* the whole document *;
 [Y]  - LINDHOFER, HORST ET AL, "Bispecific antibodies target operationally tumor-specific antigens in two leukemia relapse models", BLOOD (1996), 88(12), 4651-4658 CODEN: BLOOAW;ISSN: 0006-4971, XP000616201 [Y] 1-26 * the whole document *
 [Y]  - LINDHOFER H ET AL, "Increased tumor-specificity and -elimination by selectively binding bispecific antibodies in vivo.", 25TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY FOR EXPERIMENTAL HEMATOLOGY, NEW YORK, NEW YORK, USA, AUGUST 23-27, 1996. EXPERIMENTAL HEMATOLOGY (CHARLOTTESVILLE) 24 (9). 1996. 1090. ABSTRACT 348. ISSN: 0301-472X, XP002084410 [Y] 1-26 * the whole document *
 [PY]  - WOLLENBERG B ET AL, "A bispecific antibody induces efficient killing of tumor cells: Phase I-trial in patients with HNSCC.", INTERNATIONAL SYMPOSIUM ON METASTASES IN HEAD AND NECK CANCER, KIEL, GERMANY, JANUARY 15-18, 1998. BRITISH JOURNAL OF CANCER 77 (SUPPL. 1). 1998. 46. ABSTRACT 15.16. ISSN: 0007-0920, XP002084411 [PY] 1-26 * the whole document *
 [PY]  - LINDHOFER H ET AL, "Bispecific antibodies effectively purge cancer cells from peripheral blood stem cell collections without affecting colony forming units.", 26TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY FOR EXPERIMENTAL HEMATOLOGY, CANNES, FRANCE, AUGUST 24-28, 1997. EXPERIMENTAL HEMATOLOGY (CHARLOTTESVILLE) 25 (8). 1997. 879. ABSTRACT 527. ISSN: 0301-472X, XP002048523 [PY] 1-26 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.